nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions
|
Dutt, Suparna |
|
|
2 |
19 |
p. 2568-2580 |
artikel |
2 |
An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors
|
Downey-Kopyscinski, Sondra |
|
|
2 |
19 |
p. 2443-2451 |
artikel |
3 |
ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1
|
Rohatgi, Nidhi |
|
|
2 |
19 |
p. 2467-2477 |
artikel |
4 |
Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes
|
Yokoyama, Kazuaki |
|
|
2 |
19 |
p. 2513-2521 |
artikel |
5 |
Chromosome Y–encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant
|
Wang, Wei |
|
|
2 |
19 |
p. 2419-2429 |
artikel |
6 |
Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study
|
Gillissen, Ada |
|
|
2 |
19 |
p. 2433-2442 |
artikel |
7 |
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL
|
Siekmann, Ina-Katrin |
|
|
2 |
19 |
p. 2554-2567 |
artikel |
8 |
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation
|
Schuetz, Catharina |
|
|
2 |
19 |
p. 2550-2553 |
artikel |
9 |
Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial
|
Röth, Alexander |
|
|
2 |
19 |
p. 2543-2549 |
artikel |
10 |
Editorial Board
|
|
|
|
2 |
19 |
p. i |
artikel |
11 |
Humanized GPIbα–von Willebrand factor interaction in the mouse
|
Kanaji, Sachiko |
|
|
2 |
19 |
p. 2522-2532 |
artikel |
12 |
Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia
|
Gaillard, Coline |
|
|
2 |
19 |
p. 2462-2466 |
artikel |
13 |
Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras
|
Chu, S. Haihua |
|
|
2 |
19 |
p. 2478-2490 |
artikel |
14 |
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice
|
Wei, Yue |
|
|
2 |
19 |
p. 2491-2504 |
artikel |
15 |
NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands
|
Zhao, Xiaoyi |
|
|
2 |
19 |
p. 2452-2461 |
artikel |
16 |
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified
|
Ludvigsen, Maja |
|
|
2 |
19 |
p. 2533-2542 |
artikel |
17 |
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients
|
Esrick, Erica B. |
|
|
2 |
19 |
p. 2505-2512 |
artikel |
18 |
The ASH Agenda for Hematology Research: a roadmap for advancing scientific discovery and cures for hematologic diseases
|
Mullighan, Charles G. |
|
|
2 |
19 |
p. 2430-2432 |
artikel |